Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Niki Millward"'
Autor:
Daniel D. Shapiro, Niki Millward Zacharias, Durga N. Tripathi, Menuka Karki, Jean‐Philippe Bertocchio, Melinda Soeung, Rong He, Mary E. Westerman, Jianjun Gao, Priya Rao, Truong N. A. Lam, Eric Jonasch, Luigi Perelli, Emily H. Cheng, Alessandro Carugo, Timothy P. Heffernan, Cheryl L. Walker, Giannicola Genovese, Nizar M. Tannir, Jose A. Karam, Pavlos Msaouel
Publikováno v:
Clinical and Translational Medicine, Vol 13, Iss 5, Pp n/a-n/a (2023)
Abstract Background Renal medullary carcinoma (RMC) is a highly aggressive cancer in need of new therapeutic strategies. The neddylation pathway can protect cells from DNA damage induced by the platinum‐based chemotherapy used in RMC. We investigat
Externí odkaz:
https://doaj.org/article/fca066ea851948459db5570b929f6a14
Autor:
Shapiro, Daniel D.1,2 (AUTHOR), Zacharias, Niki Millward3 (AUTHOR), Tripathi, Durga N.4 (AUTHOR), Karki, Menuka5 (AUTHOR), Bertocchio, Jean‐Philippe5 (AUTHOR), Soeung, Melinda5 (AUTHOR), He, Rong5 (AUTHOR), Westerman, Mary E.3 (AUTHOR), Gao, Jianjun5 (AUTHOR), Rao, Priya6 (AUTHOR), Lam, Truong N. A.5 (AUTHOR), Jonasch, Eric5 (AUTHOR), Perelli, Luigi5 (AUTHOR), Cheng, Emily H.7 (AUTHOR), Carugo, Alessandro8,9,10 (AUTHOR), Heffernan, Timothy P.8,9 (AUTHOR), Walker, Cheryl L.4 (AUTHOR), Genovese, Giannicola5,11,12 (AUTHOR), Tannir, Nizar M.5 (AUTHOR), Karam, Jose A.3,13 (AUTHOR)
Publikováno v:
Clinical & Translational Medicine. May2023, Vol. 13 Issue 5, p1-18. 18p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Melinda Soeung, Luigi Perelli, Ziheng Chen, Eleonora Dondossola, I-Lin Ho, Federica Carbone, Li Zhang, Hania Khan, Courtney N. Le, Cihui Zhu, Michael D. Peoples, Ningping Feng, Shan Jiang, Niki Millward Zacharias, Rosalba Minelli, Daniel D. Shapiro, Angela K. Deem, Sisi Gao, Emily H. Cheng, Donatella Lucchetti, Cheryl L. Walker, Alessandro Carugo, Virginia Giuliani, Timothy P. Heffernan, Andrea Viale, Nizar M. Tannir, Giulio F. Draetta, Pavlos Msaouel, Giannicola Genovese
Publikováno v:
Proceedings of the National Academy of Sciences. 120
Renal medullary carcinoma (RMC) is an aggressive kidney cancer that almost exclusively develops in individuals with sickle cell trait (SCT) and is always characterized by loss of the tumor suppressor SMARCB1 . Because renal ischemia induced by red bl
Autor:
Kyle Rose, Darren Sanchez, Arfa Mustasam, Kathryn Marchetti, Reagan Sandstrom, Lance Pagliaro, Niki Millward, Constantine Alifrangis, Kelvin Moses, Maarten Albersen, Eduard Roussel, Viraj Master, Bahzel Nazha, Tony Zhuang, Jeffrey Montgomery, Chris Protzel, Marcos Tobias-Machado, Philippe Spiess, Curtis Pettaway, Jad Chahoud
Publikováno v:
Journal of Urology. 209
Autor:
Daniel Shapiro, Niki Millward Zacharias, Durga Tripathi, Jean-Philippe Bertocchio, Melinda Soeung, Rong He, Jianjun Gao, Priya Rao, Truong Lam, Luigi Perelli, Alessandro Carugo, Timothy Heffernan, Cheryl Walker, Giannicola Genovese, Nizar Tannir, Christopher Wood, Jose Karam, Pavlos Msaouel
Publikováno v:
Journal of Urology. 207
Autor:
Durga Nand Tripathi, Cheryl L. Walker, Daniel J. Shapiro, Priya Rao, Pavlos Msaouel, Giannicola Genovese, Jose A. Karam, Nizar M. Tannir, Jean-Philippe Bertocchio, Niki Millward Zacharias, Christopher G. Wood, Melinda Soeung
Publikováno v:
Journal of Urology. 206
INTRODUCTION AND OBJECTIVE:Renal medullary carcinoma (RMC) is a rare and aggressive malignancy that primarily affects young patients of African descent with sickle cell trait. No targeted therapies...
Autor:
Nizar M. Tannir, Cheryl L. Walker, Durga Nand Tripathi, Priya Rao, Jose A. Karam, Christopher G. Wood, Giannicola Genovese, Niki Millward Zacharias, Melinda Soeung, Jean-Philippe Bertocchio, Pavlos Msaouel, Daniel D. Shapiro
Publikováno v:
Cancer Research. 81:1247-1247
Renal medullary carcinoma (RMC) is a rare and highly aggressive malignancy that affects primarily young patients of African descent with sickle cell trait. No targeted therapies are currently approved for patients with RMC and the median survival fro
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.